The Experts below are selected from a list of 11172 Experts worldwide ranked by ideXlab platform

Richard M Obrien - One of the best experts on this subject based on the ideXlab platform.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

Cyrus C Martin - One of the best experts on this subject based on the ideXlab platform.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

Christina A Svitek - One of the best experts on this subject based on the ideXlab platform.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

James K Oeser - One of the best experts on this subject based on the ideXlab platform.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

Eva Henderson - One of the best experts on this subject based on the ideXlab platform.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

  • upstream stimulatory Factor usf and neurogenic differentiation beta cell e box Transactivator 2 neurod beta2 contribute to islet specific glucose 6 phosphatase catalytic subunit related protein igrp gene expression
    Biochemical Journal, 2003
    Co-Authors: Cyrus C Martin, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M Obrien
    Abstract:

    Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetylTransferase (CAT) fusion-gene expression through Transient Transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with Trans -Acting Factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional Trans -Acting Factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box Transactivator 2) and upstream stimulatory Factor (USF) in vitro, consistent with the binding of both Factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.